332.29999 EUR
0.6
0.18%
Last update Dec 16, 9:55 PM CET
Main market
Day range
330
332.70001
Previous close
332.89999
Open
330
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
332.30
0.60
0.18%

Financials

Cash flow

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Operating activities 206.3M 111.1M -123.9M -103.5M
Net income 214.0M -56.5M -49.0M -71.4M
Depreciation 11.8M 11.9M 12.3M -17.5M
Deferred taxes 4.8M 8.3M 8.2M
StockBased compensation 92.2M 95.2M 48.3M 78.1M
Other non cash items 40.3M 15.3M 13.3M 24.3M
Accounts receivable -340.8M -116.7M -6.3M -50.7M
Accounts payable 190.5M 155.2M -132.7M -52.9M
Other assets liabilities -6.4M -1.6M -18.0M -13.4M
Investing activities 428.9M -120.5M 97.0M -45.1M
Capital expenditures -10.3M -12.2M -7.6M -7.8M
Net intangibles
Net acquisitions
Purchase of investments -177.2M -391.7M -342.3M -414.8M
Sale of investments 616.5M 283.3M 446.9M 377.6M
Other investing activity -99.7K
Financing activities -29.4M -23.4M -4.5M -4.5M
Long term debt issuance
Long term debt payments
Short term debt issuance
Common stock issuance
Common stock repurchase
Common dividends
Other financing charges -29.4M -23.4M -4.5M -4.5M
End cash position 1.3B 951.0M 871.2M 825.5M
Income tax paid 1.1M -1.6M 2.5M
Interest paid 20.4M 12.4M 57.0M 10.5M
Free cash flow 266.7M 118.8M -108.5M -88.4M
Access the full /cash_flow historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours 31 minutes

12:28
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).